PMID: 9541443Apr 16, 1998Paper

Cyclosporin-A therapy in severe uveitis of Behçet's disease

Acta Ophthalmologica Scandinavica
Y SüllüF Mohajeri

Abstract

Cyclosporine-A (CSA) combined with corticosteroid therapy was administered to 12 patients with severe Behçet's uveitis who were resistant to colchicine or cytotoxic therapy. Previous colchicine or cytotoxic therapies were tapered off one month before CSA therapy. All patients were started on an initial oral dose of 5 mg/kg/day of CSA. After the first three months, the CSA dose was reduced to a maintenance dose according to the intraocular inflammatory response. The average follow-up period was 20 (12-36) months. Visual acuity remained the same in 12 (%54.5) and improved in 8 (%36.4) eyes. There was a decrease in the frequency (p<0.01) and severity (p<0.01) of ocular attacks and in the maintenance steroid dose (p<0.01) when compared with conventional therapy. The frequent side effects were paraesthesia-hyperesthesia, fatigue, nausea, hirsutism and dose-related nephrotoxicity in one patient. The results of the study suggest that low dose CSA combined with low dose corticosteroid may be an effective therapeutic alternative in the treatment of severe refractory Behçet's uveitis.

Citations

Sep 16, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Xiaoguang DongPing Lin
Jan 21, 2014·La Revue de médecine interne·C ComarmondD Saadoun
Aug 3, 2007·Transactions of the Royal Society of Tropical Medicine and Hygiene·S N S MarloweD N J Lockwood
Apr 11, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tekin AkpolatMelda Dilek
Mar 30, 2005·Journal of Biomaterials Science. Polymer Edition·Hai-Quan MaoKam W Leong
Jan 25, 2002·The Bulletin of Tokyo Dental College·T HisamatsuJ Nishida
Dec 24, 2009·Indian Journal of Ophthalmology·Reema BansalAmod Gupta
Jun 5, 2007·La Presse médicale·Mohamed Habib HoumanKamel Hamzaoui
Jul 15, 2015·Ocular Immunology and Inflammation·Kenichi NambaShigeaki Ohno
Nov 29, 2011·Survey of Ophthalmology·Khayyam DurraniC Stephen Foster
Apr 24, 2010·La Revue de médecine interne·D SaadounP Cacoub
Feb 6, 2007·La Revue de médecine interne·D Le Thi HuongJ-C Piette
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Cem Evereklioglu
Jul 27, 2010·Seminars in Arthritis and Rheumatism·Esperanza PatoUNKNOWN Uveitis Working Group from Spanish Society of Rheumatology
May 3, 2014·Therapeutic Advances in Chronic Disease·Zeinab Saleh, Thurayya Arayssi
Jan 23, 1999·Current Opinion in Rheumatology·W L Gross
Mar 23, 2001·Ocular Immunology and Inflammation·B WechslerP LeHoang
Feb 9, 2000·Journal of the American Society of Nephrology : JASN·Elias David-NetoLuis Estevan Ianhez
Jun 3, 2021·Journal of Clinical Medicine·Julie GueudryBahram Bodaghi
Jun 22, 2005·Survey of Ophthalmology·Cem Evereklioglu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.